There is a vast body of literature on the importance of VEGF in neoplastic disease, including an earlier comprehensive review by Goel and Mercurio [63], and recent efforts to block certain particularly aggressive cancers depend on the binding of VEGF to a co-factor, neuropillin-2 [64]. The gene discussed is VEGFA; the disease is neoplasm.